Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Vangieri

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
La Clinica Terapeutica|September 4, 2004
The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospectF Marotta, B Vangieri, A Cecere, et al.
La Clinica Terapeutica|October 24, 2007
[Secondary pulmonary hypertension in the elderly: pathophysiological and clinical aspects from an observed case]B Vangieri, A Parlato, G Mirra, et al.
La Clinica Terapeutica|October 21, 2006
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts)A Gattoni, A Parlato, B Vangieri, et al.
Panminerva Medica|October 29, 2004
Progressive liver injury in chronic hepatitis C infection is related to altered cellular immune response and to different citokine profileA Cecere, F Marotta, B Vangieri, et al.
Minerva Gastroenterologica E Dietologica|March 24, 2009
Chronic hepatitis C in the advanced adult and elderly subjectsA Gattoni, A Parlato, B Vangieri, et al.
La Clinica Terapeutica|December 7, 2006
Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts)A Gattoni, A Parlato, B Vangieri, et al.
La Clinica Terapeutica|February 11, 2005
Hepatorenal syndromeA Gattoni, F Marotta, B Vangieri, et al.
Panminerva Medica|October 28, 2009
The use of IFN-alpha in subjects with liver transplant for hepatitis CA Gattoni, E Plaitano, B Vangieri, et al.
Panminerva Medica|June 23, 2004
High prevalence of hepatitis C virus infection in a southern Italian rural region. Clinical aspects and evidence of inapparent parenteral exposureA Cecere, F Marotta, A Lucariello, et al.
La Clinica Terapeutica|May 4, 2006
Role of hemochromatosis genes in chronic hepatitis CA Gattoni, A Parlato, B Vangieri, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
La Clinica Terapeutica|September 4, 2004
The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospectF Marotta, B Vangieri, A Cecere, et al.
La Clinica Terapeutica|October 24, 2007
[Secondary pulmonary hypertension in the elderly: pathophysiological and clinical aspects from an observed case]B Vangieri, A Parlato, G Mirra, et al.
La Clinica Terapeutica|October 21, 2006
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts)A Gattoni, A Parlato, B Vangieri, et al.
Panminerva Medica|October 29, 2004
Progressive liver injury in chronic hepatitis C infection is related to altered cellular immune response and to different citokine profileA Cecere, F Marotta, B Vangieri, et al.
Minerva Gastroenterologica E Dietologica|March 24, 2009
Chronic hepatitis C in the advanced adult and elderly subjectsA Gattoni, A Parlato, B Vangieri, et al.
La Clinica Terapeutica|December 7, 2006
Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts)A Gattoni, A Parlato, B Vangieri, et al.
La Clinica Terapeutica|February 11, 2005
Hepatorenal syndromeA Gattoni, F Marotta, B Vangieri, et al.
Panminerva Medica|October 28, 2009
The use of IFN-alpha in subjects with liver transplant for hepatitis CA Gattoni, E Plaitano, B Vangieri, et al.
Panminerva Medica|June 23, 2004
High prevalence of hepatitis C virus infection in a southern Italian rural region. Clinical aspects and evidence of inapparent parenteral exposureA Cecere, F Marotta, A Lucariello, et al.
La Clinica Terapeutica|May 4, 2006
Role of hemochromatosis genes in chronic hepatitis CA Gattoni, A Parlato, B Vangieri, et al.
Pageof 1